Preferred Label : Bridged Bicyclo Compounds, Heterocyclic;

MeSH definition : A class of saturated compounds consisting of two rings only, having two or more atoms in common, containing at least one hetero atom, and that take the name of an open chain hydrocarbon containing the same total number of atoms. (From Riguady et al., Nomenclature of Organic Chemistry, 1979, p31); Heterocyclic compounds that contain two rings that share two non-adjacent atoms in common.;

MeSH synonym : heterocyclic bicyclo compounds; heterocyclic compounds, bicyclic; heterocyclic cpds, bicyclic; bicyclic heterocyclic cpds; bicyclic heterocyclic compounds; Bicyclo Compounds, Heterocyclic;

CISMeF synonym : compounds, bicyclic heterocyclic; cpds, bicyclic heterocyclic; compounds, heterocyclic bicyclo;

MeSH annotation : DF: BICYCLO CPDS HETEROCYCLIC; general or unspecified; prefer specifics;

Wikipedia link : https://en.wikipedia.org/wiki/Bicyclo compounds, heterocyclic;

Is substance : O;

Details


Main resources

You can consult :

A class of saturated compounds consisting of two rings only, having two or more atoms in common, containing at least one hetero atom, and that take the name of an open chain hydrocarbon containing the same total number of atoms. (From Riguady et al., Nomenclature of Organic Chemistry, 1979, p31)
Heterocyclic compounds that contain two rings that share two non-adjacent atoms in common.

https://ansm.sante.fr/tableau-atu-rtu/venclyxto-10-mg-50mg-100-mg-comprimes-pellicules
2023
false
false
false
France
French
venetoclax
venetoclax
Recurrent Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
leukemia, myeloid, acute
precursor cell lymphoblastic Leukemia-Lymphoma
Refractory Acute Lymphoblastic Leukemia
Recurrent Acute Lymphoblastic Leukemia
leukemia, lymphocytic, chronic, B-Cell
drug information
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://ansm.sante.fr/informations-de-securite/venclyxto-r-v-venetoclax-comprimes-pellicules-recommandations-actualisees-concernant-le-syndrome-de-lyse-tumorale-slt-chez-les-patients-atteints-de-leucemie-lymphoide-chronique
2021
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
venetoclax
tumor lysis syndrome
leukemia, lymphocytic, chronic, B-Cell
venetoclax
antineoplastic agents
administration, oral
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/jcms/p_3284614/fr/venclyxto-venetoclax-leucemie-aigue-myeloide
2021
false
false
false
France
evaluation of the transparency committee
venetoclax
sulfonamides
treatment outcome
insurance, health, reimbursement
administration, oral
venetoclax
leukemia, myeloid, acute
antineoplastic agents
adult
antineoplastic combined chemotherapy protocols
azacitidine
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.ema.europa.eu/en/medicines/human/EPAR/staquis
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
crisaborole
crisaborole
drug approval
europe
adult
child
adolescent
dermatitis, atopic
administration, cutaneous
ointments
crisaborole
product surveillance, postmarketing
drug interactions
breast feeding
pregnancy
phosphodiesterase 4 inhibitors
anti-inflammatory agents, non-steroidal
anti-inflammatory agents, non-steroidal
cytokines
drug evaluation, preclinical
Product containing precisely crisaborole 20 milligram/1 gram conventional release cutaneous ointment (clinical drug)
boron compounds
Bridged Bicyclo Compounds, Heterocyclic
boron compounds
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/jcms/p_3197837/fr/segluromet
2020
false
false
false
France
French
evaluation of the transparency committee
metformin and ertugliflozin
drug combinations
administration, oral
insurance, health, reimbursement
treatment outcome
hypoglycemic agents
adult
diabetes mellitus, type 2
metformin
ertugliflozin
hypoglycemic agents
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose Transporter 2 Inhibitors
ertugliflozin
metformin
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/jcms/p_3106158/fr/venclyxto
2020
false
false
false
France
venetoclax
drug therapy, combination
Rituximab
adult
leukemia, lymphocytic, chronic, B-Cell
administration, oral
antineoplastic agents
venetoclax
evaluation of the transparency committee
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/portail/jcms/c_2913813/fr/steglujan
https://www.has-sante.fr/portail/jcms/c_2913813/fr/steglujan-ertugliflozine-sitagliptine-antidiabetique-oral
2019
false
true
false
false
France
French
SGLT2 Inhibitor
hypoglycemic agents
drug combinations
administration, oral
treatment outcome
sitagliptin and ertugliflozin
diabetes mellitus, type 2
drug interactions
adult
Sodium-Glucose transporter 2
Sitagliptin Phosphate
incretins
dipeptidyl-peptidase iv inhibitors
evaluation of the transparency committee
Sodium-Glucose Transporter 2 Inhibitors
guidelines for drug use
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/jcms/p_3106167/fr/venclyxto
2019
false
false
false
France
French
evaluation of the transparency committee
venetoclax
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.ansm.sante.fr/actualites/venclyxto-venetoclax-signal-de-securite-issu-de-lessai-clinique-evaluant-le-venetoclax-dans-le-traitement-du-myelome-multiple
2019
false
false
false
France
French
pharmacovigilance note
clinical trials as topic
multiple myeloma
Infections
Infections
venetoclax
antineoplastic agents
venetoclax
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/portail/jcms/c_2913810/fr/steglatro
https://www.has-sante.fr/portail/jcms/c_2913810/fr/steglatro-ertugliflozine-antidiabetique-oral
2019
false
false
false
false
France
French
administration, oral
diabetes mellitus, type 2
treatment outcome
hypoglycemic agents
adult
ertugliflozin
SGLT2 Inhibitor
Sodium-Glucose transporter 2
evaluation of the transparency committee
Sodium-Glucose Transporter 2 Inhibitors
guidelines for drug use
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic

---
Steglatro - ertugliflozin
https://www.ema.europa.eu/medicines/human/EPAR/Steglatro
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
administration, oral
diabetes mellitus, type 2
drug approval
europe
treatment outcome
hypoglycemic agents
hypoglycemic agents
product surveillance, postmarketing
drug monitoring
adult
ertugliflozin
SGLT2 Inhibitor
SGLT2 Inhibitor
Sodium-Glucose transporter 2
drug interactions
pregnancy
breast feeding
drug therapy, combination
Sodium-Glucose Transporter 2 Inhibitors
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
ertugliflozin
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic

---
Segluromet ertugliflozin / metformin hydrochloride
https://www.ema.europa.eu/medicines/human/EPAR/Segluromet
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
SGLT2 Inhibitor
SGLT2 Inhibitor
metformin
hypoglycemic agents
hypoglycemic agents
drug combinations
administration, oral
europe
drug approval
treatment outcome
product surveillance, postmarketing
drug monitoring
metformin and ertugliflozin
diabetes mellitus, type 2
drug interactions
pregnancy
breast feeding
adult
Metformin Hydrochloride
Metformin Hydrochloride
drug evaluation, preclinical
Sodium-Glucose transporter 2
Sodium-Glucose Transporter 2 Inhibitors
metformin
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
ertugliflozin
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00403
2018
false
false
false
Canada
French
drug information
administration, oral
hypoglycemic agents
hypoglycemic agents
diabetes mellitus, type 2
Sodium-Glucose transporter 2
drug approval
canada
treatment outcome
adult
drug therapy, combination
ertugliflozin
Sodium-Glucose Transporter 2 Inhibitors
ertugliflozin
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00406
2018
false
false
false
Canada
French
drug information
drug approval
canada
administration, topical
ointments
phosphodiesterase 4 inhibitors
phosphodiesterase 4 inhibitors
child
adolescent
adult
dermatitis, atopic
treatment outcome
crisaborole
Eucrisa
crisaborole
crisaborole
boron compounds
Bridged Bicyclo Compounds, Heterocyclic
boron compounds
Bridged Bicyclo Compounds, Heterocyclic

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00339
2018
false
false
false
Canada
French
English
drug information
venetoclax
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
Steglujan - ertugliflozin / sitagliptin
https://www.ema.europa.eu/medicines/human/EPAR/Steglujan
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
SGLT2 Inhibitor
SGLT2 Inhibitor
hypoglycemic agents
hypoglycemic agents
drug combinations
administration, oral
europe
drug approval
treatment outcome
product surveillance, postmarketing
drug monitoring
sitagliptin and ertugliflozin
diabetes mellitus, type 2
drug interactions
pregnancy
breast feeding
adult
drug evaluation, preclinical
Sodium-Glucose transporter 2
Sitagliptin Phosphate
Sitagliptin Phosphate
incretins
incretins
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
Sodium-Glucose Transporter 2 Inhibitors
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
ertugliflozin
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/portail/jcms/c_2788624/fr/venclyxto
https://www.has-sante.fr/portail/jcms/c_2788624/fr/venclyxto-venetoclax-inhibiteur-de-bcl-2
2017
false
false
false
France
French
treatment outcome
orphan drug production
leukemia, lymphocytic, chronic, B-Cell
administration, oral
B-Cell leukemia 2 family proteins
antineoplastic agents
antineoplastic agents
leukemia, lymphocytic, chronic, B-Cell
Loss of Chromosome 17p
genes, p53
mutation
adult
aged
venetoclax
evaluation of the transparency committee
venetoclax
venetoclax
Proto-Oncogene proteins c-bcl-2
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.ema.europa.eu/medicines/human/EPAR/Venclyxto
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
venetoclax
venetoclax
leukemia, lymphocytic, chronic, B-Cell
drug approval
europe
risk assessment
pregnancy
breast feeding
drug interactions
administration, oral
B-Cell leukemia 2 family proteins
antineoplastic agents
antineoplastic agents
leukemia, lymphocytic, chronic, B-Cell
Loss of Chromosome 17p
genes, p53
product surveillance, postmarketing
mutation
continuity of patient care
drug monitoring
adult
aged
drug evaluation, preclinical
Response Rate
venetoclax
venetoclax
venetoclax
Proto-Oncogene proteins c-bcl-2
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://ansm.sante.fr/tableau-atu-rtu/venetoclax-abbvie-10-mg-50-mg-et-100-mg-comprimes-pellicules
2016
false
false
false
France
French
summary of product characteristics
package leaflet
guidelines for drug use
adult
leukemia, lymphocytic, chronic, B-Cell
chromosome 17 deletion
mutation
TP53 Gene
venetoclax
administration, oral
antineoplastic agents
drug evaluation, preclinical
treatment outcome
Proto-Oncogene proteins c-bcl-2
venetoclax
venetoclax
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic
Smith-Magenis syndrome
chromosome deletion
chromosomes, human, pair 17

---
https://www.ema.europa.eu/medicines/human/EPAR/Altargo
2012
false
United Kingdom
French
English
syndication feed
antibiotic therapy
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment (clinical drug)
anti-bacterial agents
ointments
skin diseases, bacterial
treatment outcome
drug evaluation
adult
adolescent
infant
child
Bridged Bicyclo Compounds, Heterocyclic
anti-bacterial agents
administration, cutaneous
drug interactions
pregnancy
breast feeding
Bridged Bicyclo Compounds, Heterocyclic
anti-bacterial agents
drug resistance, bacterial
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic
anti-bacterial agents
anti-bacterial agents
Bridged Bicyclo Compounds, Heterocyclic
anti-bacterial agents
drug evaluation, preclinical
drug labeling
impetigo
Bridged Bicyclo Compounds, Heterocyclic
drug approval
retapamulin
retapamulin
Bridged Bicyclo Compounds, Heterocyclic
drug evaluation
summary of product characteristics
package leaflet

---
http://unt-ori2.crihan.fr/unspf/2010_Lyon1_Radix_HeterocyclesAromatiques.pdf
2010
true
false
true
France
heterocyclic compounds
problems and exercises
education, pharmacy
chemistry, organic
Bridged Bicyclo Compounds, Heterocyclic
heterocyclic compounds, 1-ring

---
http://unt-ori2.crihan.fr/unspf/2010_Lyon1_Nebois_HeterocycliquesAromatiques.pdf
2010
true
false
true
France
educational course
education, pharmacy
chemistry, organic
Bridged Bicyclo Compounds, Heterocyclic

---
Nous contacter.
11/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.